Display options
Share it on

Dermatoendocrinol. 2010 Apr;2(2):68-76. doi: 10.4161/derm.2.2.13812.

An ecological study of cancer mortality rates in the United States with respect to solar ultraviolet-B doses, smoking, alcohol consumption and urban/rural residence.

Dermato-endocrinology

William B Grant

Affiliations

  1. Sunlight, Nutrition and Health Research Center (SUNARC); San Francisco, CA USA.

PMID: 21547102 PMCID: PMC3081680 DOI: 10.4161/derm.2.2.13812

Abstract

The Cohort Consortium Vitamin D Polling Project of Rarer Cancers (VDPP ) study failed to find a beneficial role of prediagnostic serum 25-hydroxyvitamin D [25(OH)D] levels on risk of seven types of rarer cancer: endometrial, esophageal, gastric, kidney, ovarian and pancreatic cancer and non-Hodgkin's lymphoma (NHL). However, ecological studies and studies of oral vitamin D intake have generally found solar ultraviolet B (UVB) and oral vitamin D inversely correlated with incidence and/or mortality rates of these cancers. To explore the discrepancy, I conducted an ecological study of cancer mortality rates for white Americans in the United States for 1950-1994 with data for 503 state economic areas in multiple linear regression analyses with respect to UVB for July, lung cancer, alcohol consumption and urban/rural residence. UVB was significantly inversely correlated with six types of cancer (not pancreatic cancer) in both periods. However, the adjusted R(2) values were much lower for cancers with lower mortality rates than those in an earlier ecological study that used state-averaged data. This finding suggests that the VDPP study may have had too few cases. Thus, the VDPP study should not be considered as providing strong evidence against the solar UVB-vitamin D-cancer hypothesis.

Keywords: alcohol consumption; cancer; ecological study; smoking; ultraviolet-B; vitamin D

References

  1. Anticancer Res. 2008 May-Jun;28(3B):1955-63 - PubMed
  2. Breast J. 2008 May-Jun;14(3):255-60 - PubMed
  3. Oncogene. 2002 Oct 21;21(48):7307-25 - PubMed
  4. Cancer. 2002 Jan 1;94(1):272-81 - PubMed
  5. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):343-8 - PubMed
  6. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):456-8 - PubMed
  7. Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):525-31 - PubMed
  8. BMJ. 1997 May 17;314(7092):1451-5 - PubMed
  9. Int J Epidemiol. 1994 Dec;23(6):1133-6 - PubMed
  10. Cancer Causes Control. 1997 May;8(3):271-83 - PubMed
  11. Am J Pathol. 2008 Nov;173(5):1589-90 - PubMed
  12. Anticancer Res. 2006 Jul-Aug;26(4A):2687-99 - PubMed
  13. Recent Results Cancer Res. 2003;164:371-7 - PubMed
  14. Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):303-11 - PubMed
  15. Altern Med Rev. 2008 Mar;13(1):6-20 - PubMed
  16. Gynecol Oncol. 2010 Nov;119(2):314-8 - PubMed
  17. J Clin Endocrinol Metab. 2011 Jan;96(1):53-8 - PubMed
  18. Int J Cancer. 2007 Mar 1;120(5):1123-8 - PubMed
  19. Anticancer Res. 2010 Jan;30(1):189-99 - PubMed
  20. Am J Prev Med. 2006 Dec;31(6):512-4 - PubMed
  21. Aliment Pharmacol Ther. 2009 Jul 1;30(2):113-25 - PubMed
  22. Lung Cancer. 2004 Aug;45 Suppl 2:S3-9 - PubMed
  23. Int J Cancer. 1998 Mar 30;76(1):7-12 - PubMed
  24. Prev Med. 1990 Nov;19(6):614-22 - PubMed
  25. Am J Clin Nutr. 2007 Jan;85(1):6-18 - PubMed
  26. Breast Cancer Res Treat. 2010 Aug;123(1):233-43 - PubMed
  27. Expert Opin Pharmacother. 2008 Jan;9(1):107-18 - PubMed
  28. Int J Cancer. 2006 Dec 1;119(11):2705-9 - PubMed
  29. Dermatoendocrinol. 2009 Jan;1(1):25-33 - PubMed
  30. Mol Nutr Food Res. 2010 Aug;54(8):1172-81 - PubMed
  31. J Natl Cancer Inst. 2006 Apr 5;98(7):451-9 - PubMed
  32. Gynecol Oncol. 2010 Aug 1;118(2):202-7 - PubMed
  33. Eur J Cancer. 2010 Oct;46(15):2799-805 - PubMed
  34. Proc R Soc Med. 1965 May;58:295-300 - PubMed
  35. Am J Clin Nutr. 2007 Jun;85(6):1586-91 - PubMed
  36. Br J Cancer. 2010 Apr 27;102(9):1422-7 - PubMed
  37. Anticancer Res. 1990 Sep-Oct;10(5A):1307-11 - PubMed
  38. Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):236-42 - PubMed
  39. Photochem Photobiol. 2008 Mar-Apr;84(2):356-65 - PubMed
  40. Eur J Cancer. 2010 Aug;46(12):2196-205 - PubMed
  41. J Water Health. 2010 Mar;8(1):192-203 - PubMed
  42. Lung Cancer. 2002 Jan;35(1):43-51 - PubMed
  43. Sci Am. 1996 Jul;275(1):52-3, 56-9 - PubMed
  44. Prev Med. 2004 May;38(5):511-5 - PubMed
  45. J Natl Cancer Inst. 2005 Feb 2;97(3):199-209 - PubMed
  46. Alcohol Res Health. 2007;30(1):38-41, 44-7 - PubMed
  47. Cancer. 2002 Mar 15;94(6):1867-75 - PubMed
  48. Pancreas. 2009 May;38(4):387-90 - PubMed
  49. Anticancer Res. 2006 Jul-Aug;26(4A):2605-14 - PubMed
  50. Occup Med (Lond). 2002 May;52(3):157-64 - PubMed
  51. Ann Epidemiol. 2009 Jul;19(7):446-54 - PubMed
  52. Oncology. 2002;63(2):151-7 - PubMed
  53. Am J Clin Nutr. 2003 Jan;77(1):204-10 - PubMed
  54. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1283-6 - PubMed
  55. Br J Cancer. 2009 Aug 4;101(3):537-40 - PubMed
  56. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):938-45 - PubMed
  57. Int J Health Geogr. 2007 Jul 26;6:34 - PubMed
  58. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):59-64 - PubMed
  59. Tenn Med. 2010 Aug;103(7):51-2, 57 - PubMed
  60. Prev Med. 2007 Nov;45(5):327-31 - PubMed
  61. Int J Cancer. 2007 Feb 15;120(4):892-6 - PubMed
  62. Arch Intern Med. 2009 Mar 23;169(6):626-32 - PubMed
  63. Prostate Cancer Prostatic Dis. 2009;12(3):215-26 - PubMed
  64. Int J Cancer. 2011 Mar 15;128(6):1414-24 - PubMed
  65. Int J Cancer. 2004 Dec 10;112(5):865-71 - PubMed
  66. Dermatoendocrinol. 2009 Jan;1(1):17-24 - PubMed
  67. Jpn J Clin Oncol. 1985 Jun;15(2):403-13 - PubMed
  68. Am J Public Health. 2006 Feb;96(2):252-61 - PubMed
  69. Am J Epidemiol. 2010 Jul 1;172(1):4-9 - PubMed
  70. Curr Drug Targets. 2011 Jan;12(1):4-18 - PubMed
  71. BMC Cancer. 2006 Nov 10;6:264 - PubMed
  72. Eur J Cancer. 2007 Jul;43(11):1701-12 - PubMed
  73. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1688-95 - PubMed
  74. Int J Cancer. 2008 Jan 1;122(1):144-54 - PubMed
  75. Cancer Epidemiol. 2009 Dec;33(6):435-45 - PubMed
  76. Am J Epidemiol. 2010 Nov 15;172(10):1210-1; author reply 1211-2 - PubMed
  77. Dermatoendocrinol. 2009 Jul;1(4):207-14 - PubMed
  78. Int J Epidemiol. 1980 Sep;9(3):227-31 - PubMed
  79. Cancer. 2000 Jun 1;88(11):2642-52 - PubMed
  80. Occup Environ Med. 2002 Apr;59(4):257-62 - PubMed
  81. Am J Epidemiol. 2007 Dec 15;166(12):1409-19 - PubMed
  82. Ann Oncol. 2006 Apr;17(4):713-8 - PubMed
  83. Adv Exp Med Biol. 2008;624:104-16 - PubMed
  84. Health Phys. 2004 Nov;87(5):532-8 - PubMed
  85. Pancreas. 2010 Jul;39(5):669-74 - PubMed
  86. Anticancer Res. 2009 Sep;29(9):3537-45 - PubMed
  87. J Bone Miner Res. 2003 Mar;18(3):579-82 - PubMed
  88. Ann Epidemiol. 2007 Dec;17(12):956-63 - PubMed
  89. Prog Biophys Mol Biol. 2009 Feb-Apr;99(2-3):104-13 - PubMed
  90. J Natl Med Assoc. 2006 Mar;98(3):357-64 - PubMed
  91. Int J Cancer. 2008 Feb 15;122(4):924-9 - PubMed
  92. Curr Med Res Opin. 2008 Jan;24(1):139-49 - PubMed
  93. Rev Epidemiol Sante Publique. 1993;41(5):374-82 - PubMed
  94. Cancer Causes Control. 2010 Oct;21(10):1701-9 - PubMed
  95. Ann Epidemiol. 2009 Feb;19(2):79-83 - PubMed
  96. Anticancer Res. 2009 Sep;29(9):3687-98 - PubMed
  97. J Photochem Photobiol B. 2010 Nov 3;101(2):130-6 - PubMed
  98. Am J Clin Nutr. 2010 May;91(5):1255-60 - PubMed

Publication Types